Vladyslav Sukhin

Prof. Dr. Vladyslav Sukhin

Grigoriev Institute for Medical Radiology and Oncology, National Academy of Medical Sciences of Ukraine, Kharkiv, Kharkivs’ka Oblast’, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in The Lancet
Verified
Journal Article
Closed access
Domenica LorussoDomenica Lorusso
Domenica Lorusso
YXYang Xiang
Yang Xiang
KHKosei Hasegawa
Kosei Hasegawa
GSGiovanni Scambia
Giovanni Scambia
MLManuel Leiva
Manuel Leiva
LDLinda R Duska
Linda R Duska

1 September 2020 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
LCLuis Chiva
Luis Chiva
VZVanna Zanagnolo
Vanna Zanagnolo
DQDenis Querleu
Denis Querleu
Nerea Martin-CalvoNerea Martin-Calvo
Nerea Martin-Calvo
JAJuan Arévalo-Serrano
Juan Arévalo-Serrano
JAJuan Luis Alcazar
Juan Luis Alcazar
Background Minimally invasive surgery in cervical cancer has demonstrated in recent publications worse outcomes than open surgery. The primary objective of the SUCCOR study, a European, multicenter, retrospective, observational cohort study was to evaluate disease-free survival in patients with stage IB1 (FIGO 2009) cervical cancer undergoing open vs minimally invasive radical hysterectomy. As a secondary objective, we aimed to investigate the association between protective surgical maneuvers and the risk of relapse. Methods We obtained data from 1272 patients that underwent a radical hysterectomy by open or minimally invasive surgery for stage IB1 cervical cancer (FIGO 2009) from January 2013 to December 2014. After applying all the inclusion-exclusion criteria, we used an inverse probability weighting to construct a weighted cohort of 693 patients to compare outcomes (minimally invasive surgery vs open). The first endpoint compared disease-free survival at 4.5 years in both groups. Secondary endpoints compared overall survival among groups and the impact of the use of a uterine manipulator and protective closure of the colpotomy over the tumor in the minimally invasive surgery group. Results Mean age was 48.3 years (range; 23–83) while the mean BMI was 25.7 kg/m2 (range; 15–49). The risk of recurrence for patients who underwent minimally invasive surgery was twice as high as that in the open surgery group (HR, 2.07; 95% CI, 1.35 to 3.15; P=0.001). Similarly, the risk of death was 2.42-times higher than in the open surgery group (HR, 2.45; 95% CI, 1.30 to 4.60, P=0.005). Patients that underwent minimally invasive surgery using a uterine manipulator had a 2.76-times higher hazard of relapse (HR, 2.76; 95% CI, 1.75 to 4.33; P<0.001) and those without the use of a uterine manipulator had similar disease-free-survival to the open surgery group (HR, 1.58; 95% CI, 0.79 to 3.15; P=0.20). Moreover, patients that underwent minimally invasive surgery with protective vaginal closure had similar rates of relapse to those who underwent open surgery (HR, 0.63; 95% CI, 0.15 to 2.59; P<0.52). Conclusions Minimally invasive surgery in cervical cancer increased the risk of relapse and death compared with open surgery. In this study, avoiding the uterine manipulator and using maneuvers to avoid tumor spread at the time of colpotomy in minimally invasive surgery was associated with similar outcomes to open surgery. Further prospective studies are warranted.

17 January 2022 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
ECEnrique Chacon
Enrique Chacon
NMNabil Manzour
Nabil Manzour
VZVanna Zanagnolo
Vanna Zanagnolo
DQDenis Querleu
Denis Querleu
JNJorge M Núñez-Córdoba
Jorge M Núñez-Córdoba
LCLuis Chiva
Luis Chiva
Objective To evaluate disease-free survival of cervical conization prior to radical hysterectomy in patients with stage IB1 cervical cancer (International Federation of Gynecology and Obstetrics (FIGO) 2009). Methods A multicenter retrospective observational cohort study was conducted including patients from the Surgery in Cervical Cancer Comparing Different Surgical Aproaches in Stage IB1 Cervical Cancer (SUCCOR) database with FIGO 2009 IB1 cervical carcinoma treated with radical hysterectomy between January 1, 2013, and December 31, 2014. We used propensity score matching to minimize the potential allocation biases arising from the retrospective design. Patients who underwent conization but were similar for other measured characteristics were matched 1:1 to patients from the non-cone group using a caliper width ≤0.2 standard deviations of the logit odds of the estimated propensity score. Results We obtained a weighted cohort of 374 patients (187 patients with prior conization and 187 non-conization patients). We found a 65% reduction in the risk of relapse for patients who had cervical conization prior to radical hysterectomy (hazard ratio (HR) 0.35, 95% confidence interval (CI) 0.16 to 0.75, p=0.007) and a 75% reduction in the risk of death for the same sample (HR 0.25, 95% CI 0.07 to 0.90, p=0.033). In addition, patients who underwent minimally invasive surgery without prior conization had a 5.63 times higher chance of relapse compared with those who had an open approach and previous conization (HR 5.63, 95% CI 1.64 to 19.3, p=0.006). Patients who underwent minimally invasive surgery with prior conization and those who underwent open surgery without prior conization showed no differences in relapse rates compared with those who underwent open surgery with prior cone biopsy (reference) (HR 1.94, 95% CI 0.49 to 7.76, p=0.349 and HR 2.94, 95% CI 0.80 to 10.86, p=0.106 respectively). Conclusions In this retrospective study, patients undergoing cervical conization before radical hysterectomy had a significantly lower risk of relapse and death.

26 June 2018 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
MRM. La Russa
M. La Russa
IZI. Zapardiel
I. Zapardiel
MHM. J. Halaska
M. J. Halaska
KZK. Zalewski
K. Zalewski
RLR. Laky
R. Laky
IBIoannis Biliatis
Ioannis Biliatis

16 May 2023 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
Ignacio ZapardielIgnacio Zapardiel
Ignacio Zapardiel
MGMyriam Gracia
Myriam Gracia
RMRonalds Macuks
Ronalds Macuks
RMRosanna Mancari
Rosanna Mancari
PAPatriciu Achimas-Cadariu
Patriciu Achimas-Cadariu
SGSARCUT Study Group
SARCUT Study Group
Objective Uterine sarcomas are a rare and heterogeneous group of malignancies that include different histological sub-types. The aim of this study was to identify and evaluate the impact of the different prognostic factors on overall survival and disease-free survival of patients with uterine sarcoma. Methods This international multicenter retrospective study included 683 patients diagnosed with uterine sarcoma at 46 different institutions between January 2001 and December 2007. Results The 5-year overall survival for leiomyosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, and adenosarcoma was 65.3%, 78.3%, 52.4%, and 89.5%, respectively, and the 5-year disease-free survival was 54.3%, 68.1%, 40.3%, and 85.3%, respectively. The 10-year overall survival for leiomyosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma and adenosarcoma was 52.6%, 64.8%, 52.4%, and 79.5%, respectively, and the 10-year disease-free survival was 44.7%, 53.3%, 40.3%, and 77.5%, respectively. The most significant factor associated with overall survival in all types of sarcoma except for adenosarcoma was the presence of residual disease after primary treatment. In adenosarcoma, disease stage at diagnosis was the most important factor (hazard ratio 17.7; 95% CI 2.86 to 109.93). Conclusion Incomplete cytoreduction, tumor persistence, advanced stage, extra-uterine and tumor margin involvement, and the presence of necrosis were relevant prognostic factors significantly affecting overall survival in uterine sarcoma. The presence of lymph vascular space involvement and administration of adjuvant chemotherapy were significantly associated with a higher risk of relapse.

1 November 2011 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
MGMurat Gultekin
Murat Gultekin
PDPolat Dursun
Polat Dursun
BVBoris Vranes
Boris Vranes
RLRene Laky
Rene Laky
MBMichaela Bossart
Michaela Bossart
VSVladyslav Sukhin
Vladyslav Sukhin